ILM1Medios AG
12.40EUR-1.12%Mkt Cap: 304.32M EURP/E: 14.16Last update: 2026-05-14

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. …

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)14.16
P/E (Forward)7.22
PEG
P/B0.59
P/S0.15
EV/EBITDA5.55
EV/Revenue0.20
EPS (TTM)0.87
EPS (Forward)1.71
Cash Flow & Leverage
FCF Yield11.81%
FCF Margin1.73%
Operating CF73.67M EUR
CapEx (TTM)6.31M EUR
Net Debt/EBITDA1.55
Net Debt117.52M EUR
Technical
SMA 5013.45 (-7.8%)
SMA 20014.27 (-13.1%)
Beta1.31
S&P 52W Chg24.23%
Avg Vol (30d)62.68K
Avg Vol (10d)84.71K
Technical Indicators
RSI (14)36.2
MACD-0.0829
MACD Signal0.0243
MACD Hist.-0.1072
BB Upper14.83 EUR
BB Middle13.55 EUR
BB Lower12.28 EUR
BB Width18.87%
ATR (14)0.6741 EUR
Vol Ratio (20d)1.41x
52W Range
11.1220% of range17.44
52W High17.44 EUR
52W Low11.12 EUR
Profitability
Gross Margin8.04%
EBITDA Margin3.64%
Profit Margin0.67%
Oper. Margin1.86%
ROE2.46%
ROA1.34%
Revenue Growth13.70%
Earnings Growth
Balance Sheet
Debt/Equity0.47
Current Ratio1.90
Quick Ratio1.35
Book Value/Sh20.98 EUR
Cash/Share3.373 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:4
Split DateJul 19, 2012
Ownership
Shares Out.24.51M
Float8.33M
Insiders19.70%
Institutions51.23%
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)23.00 EUR
Target Range18.00 EUR26.00 EUR
# Analysts4
Company
Market Cap304.32M EUR
Enterprise Value419.43M EUR
Revenue (TTM)2.08B EUR
Gross Profit151.46M EUR
Net Income (TTM)12.55M EUR
Revenue/Share83.00 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees868
Last Price12.40 EUR
CountryDE
SectorHealthcare
IndustryMedical Distribution
ISINDE000A1MMCC8